Feature | February 28, 2014

3-D Printer Creates Transformative Device for Heart Treatment

Igor Efimov, Ph.D., and a team of researchers are developing a custom-fitted, implantable device that can deliver treatment or predict an impending heart attack before a patient shows any physical symptoms. Photo by James Byard, Washington University in St. Louis

Igor Efimov, Ph.D., and a team of researchers are developing a custom-fitted, implantable device that can deliver treatment or predict an impending heart attack before a patient shows any physical symptoms. Photo by James Byard, Washington University in St. Louis

February 28, 2014 — Igor Efimov, Ph.D., from the School of Engineering and Applied Science at Washington University in St. Louis, and an international team of biomedical engineers and materials scientists have created a 3-D elastic membrane made of a soft, flexible, silicon material that is precisely shaped to match the heart's epicardium, or the outer layer of the wall of the heart.

Current technology is two-dimensional and cannot cover the full surface of the epicardium or maintain reliable contact for continual use without sutures or adhesives. The team prints tiny sensors onto the membrane that can precisely measure temperature, mechanical strain and pH, among other markers, or deliver a pulse of electricity in cases of arrhythmia. Those sensors could assist physicians with determining the health of the heart, deliver treatment or predict an impending heart attack before a patient exhibits any physical signs.

The findings were published online in Nature Communications on Feb. 25.

"Each heart is a different shape, and current devices are one-size-fits-all and don't at all conform to the geometry of a patient's heart," says Efimov, the Lucy & Stanley Lopata Distinguished Professor of Biomedical Engineering. "With this application, we image the patient's heart through MRI [magnetic resonance imaging] or CT [computed tomography], then computationally extract the image to build a 3-D model that we can print on a 3-D printer. We then mold the shape of the membrane that will constitute the base of the device deployed on the surface of the heart."

Ultimately, the membrane could be used to treat diseases of the ventricles in the lower chambers of the heart or could be inserted inside the heart to treat a variety of disorders, including atrial fibrillation, which affects 3-5 million patients in the United States.

"Currently, medical devices to treat heart rhythm diseases are essentially based on two electrodes inserted through the veins and deployed inside the chambers," Efimov says. "Contact with the tissue is only at one or two points, and it is at a very low resolution. What we want to create is an approach that will allow you to have numerous points of contact and to correct the problem with high-definition diagnostics and high-definition therapy."

Co-leading the team with Efimov is John Rogers, Ph.D., the Swanlund chair and professor of materials science and engineering and director of the F. Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign. Rogers, who developed the transfer printing technique, developed the sensors using semiconductor materials including silicon, gallium arsenide and gallium nitride, along with metals, metal oxides and polymers.

Recently, Google announced its scientists had developed a type of contact lens embedded with sensors that could monitor glucose levels in patients with diabetes. Efimov says the membrane his team has developed is a similar idea, though much more sophisticated. "Because this is implantable, it will allow physicians to monitor vital functions in different organs and intervene when necessary to provide therapy," he says. "In the case of heart rhythm disorders, it could be used to stimulate cardiac muscle or the brain, or in renal disorders, it would monitor ionic concentrations of calcium, potassium and sodium."

Efimov says the membrane could even hold a sensor to measure troponin, a protein expressed in heart cells and is a hallmark of a heart attack. Analysis for troponin is standard of care for patients with suspected heart attacks.

Ultimately, such devices will be combined with ventricular assist devices (VAD), Efimov says. "This is just the beginning. Previous devices have shown huge promise and have saved millions of lives. Now we can take the next step and tackle some arrhythmia issues that we don't know how to treat."

For more information: www.nature.com/ncomms/2014/140225/ncomms4329/full/ncomms4329.html

Related Content

News | Heart Failure| August 28, 2015
August 28, 2015 — BioControl Medical said it has completed enrollment in its INOVATE-HF (INcrease Of VAgal TonE in He
News | Hypertension| August 27, 2015
August 27, 2015 — Analysis of blood samples from more than 5,000 people suggests that a more sensitive version of a b
BioSig Technologies, research agreement, UCLA, Pure EP System, EP lab, ventricular tachycardia model, VT
Technology | EP Lab| August 20, 2015
BioSig Technologies announced it has signed a sponsored research agreement with the regents of the University of...
WomenHeart, National Policy & Science Summit on Women's Cardiovascular Health, cardiovascular disease, summit, commentary
News | Womens Healthcare| August 20, 2015
WomenHeart: The National Coalition for Women with Heart Disease announced that it will host the first National Policy...
women, blacks, larger loss of life expectancy, heart attack, JACC, study, Harlan Krumholz, Emily Bucholz
News | Womens Healthcare| August 18, 2015
Women and black patients lost more years of their expected life after a heart attack when compared to white men,...
Biotronik, BioCONTINUE study, CRT-D, defibrillator, cardiac resynchronization therapy device, heart failure, first replacement
News | Cardiac Resynchronization Therapy Devices (CRT)| August 17, 2015
Biotronik announced that the first patient has been enrolled in the BioCONTINUE clinical trial (BIOtronik study to...
CMS, additional participants, Bundled Payments for Care Improvement initiative, Medicare, eipsodes of care
News | Business| August 17, 2015
The Centers for Medicare & Medicaid Service (CMS) announced that over 2,100 healthcare facilities have agreed to...
Nonin Medical, NoninConnect Model 3230, Bluetooth Smart, wireless finger pulse oximeter, iOS-compatible, Apple

Image courtesy of Nonin Medical

Technology | Patient Monitors| August 14, 2015
August 14, 2015 — Nonin Medical Inc.
Products | Patient Monitors| August 14, 2015
News | 3-D Printing| August 13, 2015
In an effort to demonstrate how 3-D printing can help better interpret medical imaging, Philips teamed up with 3-D...
Overlay Init